Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hallucinations | 7 | 2021 | 360 | 1.940 |
Why?
|
| Psychotic Disorders | 11 | 2023 | 3040 | 1.850 |
Why?
|
| Schizophrenia | 18 | 2021 | 6874 | 1.310 |
Why?
|
| Delusions | 2 | 2013 | 300 | 0.730 |
Why?
|
| Schizophrenic Psychology | 5 | 2017 | 1677 | 0.590 |
Why?
|
| Bipolar Disorder | 9 | 2020 | 5024 | 0.510 |
Why?
|
| Auditory Cortex | 2 | 2021 | 346 | 0.480 |
Why?
|
| Substance-Related Disorders | 3 | 2023 | 4250 | 0.450 |
Why?
|
| Mental Health Services | 2 | 2020 | 1643 | 0.410 |
Why?
|
| Psychomotor Performance | 2 | 2019 | 1895 | 0.380 |
Why?
|
| Fructose | 1 | 2010 | 288 | 0.310 |
Why?
|
| Cerebellum | 3 | 2021 | 1490 | 0.300 |
Why?
|
| Public Health | 1 | 2020 | 2594 | 0.290 |
Why?
|
| Ambulatory Care | 1 | 2015 | 2706 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2021 | 35342 | 0.250 |
Why?
|
| Mental Disorders | 2 | 2022 | 6587 | 0.230 |
Why?
|
| Neuroprotective Agents | 1 | 2010 | 941 | 0.220 |
Why?
|
| Brain Mapping | 5 | 2021 | 6669 | 0.210 |
Why?
|
| Hospitals, Psychiatric | 1 | 2023 | 332 | 0.210 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3130 | 0.210 |
Why?
|
| Somatosensory Disorders | 1 | 2022 | 47 | 0.200 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3236 | 0.200 |
Why?
|
| Temporal Lobe | 2 | 2021 | 1669 | 0.190 |
Why?
|
| Pandemics | 2 | 2021 | 8328 | 0.190 |
Why?
|
| Memory | 3 | 2015 | 2163 | 0.170 |
Why?
|
| Auditory Pathways | 1 | 2021 | 233 | 0.170 |
Why?
|
| Frontal Lobe | 2 | 2016 | 1407 | 0.170 |
Why?
|
| Rest | 2 | 2015 | 900 | 0.160 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2019 | 191 | 0.150 |
Why?
|
| Amphetamine-Related Disorders | 2 | 2010 | 67 | 0.150 |
Why?
|
| Brain | 7 | 2021 | 26343 | 0.130 |
Why?
|
| Adult | 20 | 2021 | 213712 | 0.120 |
Why?
|
| Social Work | 1 | 2015 | 162 | 0.120 |
Why?
|
| Neural Pathways | 3 | 2015 | 2971 | 0.120 |
Why?
|
| Azabicyclo Compounds | 1 | 2013 | 68 | 0.110 |
Why?
|
| Patient Dropouts | 1 | 2015 | 421 | 0.110 |
Why?
|
| Social Adjustment | 1 | 2015 | 630 | 0.110 |
Why?
|
| Humans | 30 | 2023 | 742088 | 0.110 |
Why?
|
| Child Abuse | 1 | 2022 | 1030 | 0.110 |
Why?
|
| NAD | 1 | 2016 | 594 | 0.110 |
Why?
|
| Prefrontal Cortex | 2 | 2015 | 2146 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 12958 | 0.110 |
Why?
|
| Functional Laterality | 2 | 2017 | 2290 | 0.100 |
Why?
|
| Medication Adherence | 1 | 2023 | 2055 | 0.100 |
Why?
|
| Nerve Fibers, Unmyelinated | 1 | 2012 | 99 | 0.100 |
Why?
|
| Sleep Stages | 2 | 2013 | 686 | 0.100 |
Why?
|
| Suicide, Attempted | 1 | 2019 | 1218 | 0.090 |
Why?
|
| Nerve Net | 2 | 2021 | 2174 | 0.090 |
Why?
|
| Face | 1 | 2016 | 993 | 0.090 |
Why?
|
| Female | 18 | 2021 | 379592 | 0.090 |
Why?
|
| Young Adult | 8 | 2021 | 56350 | 0.090 |
Why?
|
| Psychotherapy | 1 | 2019 | 1644 | 0.090 |
Why?
|
| Neuropsychological Tests | 3 | 2019 | 6974 | 0.080 |
Why?
|
| Myelin Sheath | 1 | 2013 | 652 | 0.080 |
Why?
|
| Male | 18 | 2021 | 349538 | 0.080 |
Why?
|
| Polysomnography | 2 | 2013 | 1772 | 0.080 |
Why?
|
| Models, Neurological | 2 | 2022 | 1771 | 0.080 |
Why?
|
| Piperazines | 2 | 2013 | 2488 | 0.080 |
Why?
|
| Adolescent | 6 | 2022 | 85649 | 0.080 |
Why?
|
| Alcohol-Related Disorders | 1 | 2010 | 234 | 0.080 |
Why?
|
| Sleep | 2 | 2013 | 4604 | 0.070 |
Why?
|
| Pain | 1 | 2022 | 4961 | 0.070 |
Why?
|
| Cocaine-Related Disorders | 1 | 2010 | 460 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2016 | 3760 | 0.070 |
Why?
|
| Hypnotics and Sedatives | 1 | 2013 | 1158 | 0.060 |
Why?
|
| Oxidative Stress | 1 | 2016 | 3081 | 0.060 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 24913 | 0.060 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 1 | 2011 | 1953 | 0.060 |
Why?
|
| Axons | 1 | 2013 | 1681 | 0.060 |
Why?
|
| Severity of Illness Index | 2 | 2012 | 15530 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2015 | 2527 | 0.060 |
Why?
|
| Tobacco Use Disorder | 1 | 2010 | 685 | 0.060 |
Why?
|
| Hospitalization | 1 | 2023 | 10232 | 0.060 |
Why?
|
| Tomography, Emission-Computed | 2 | 2004 | 1144 | 0.060 |
Why?
|
| Massachusetts | 1 | 2015 | 8662 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2013 | 2304 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2013 | 6030 | 0.050 |
Why?
|
| Hippocampus | 1 | 2015 | 3661 | 0.050 |
Why?
|
| Methamphetamine | 1 | 2004 | 152 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2020 | 5304 | 0.050 |
Why?
|
| Pindolol | 1 | 2001 | 32 | 0.050 |
Why?
|
| Comorbidity | 1 | 2015 | 10372 | 0.050 |
Why?
|
| Raphe Nuclei | 1 | 2001 | 104 | 0.050 |
Why?
|
| Receptors, Serotonin | 1 | 2001 | 210 | 0.050 |
Why?
|
| Prognosis | 1 | 2020 | 29010 | 0.040 |
Why?
|
| Psychopathology | 1 | 2022 | 402 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2004 | 633 | 0.040 |
Why?
|
| Cerebral Cortex | 2 | 2012 | 5705 | 0.040 |
Why?
|
| Conditioning, Classical | 1 | 2021 | 364 | 0.040 |
Why?
|
| Catatonia | 1 | 2019 | 157 | 0.040 |
Why?
|
| Middle Aged | 5 | 2013 | 213127 | 0.030 |
Why?
|
| Opioid-Related Disorders | 1 | 2010 | 2062 | 0.030 |
Why?
|
| Employment | 1 | 2021 | 1124 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2021 | 854 | 0.030 |
Why?
|
| Mood Disorders | 1 | 2001 | 1106 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 39004 | 0.030 |
Why?
|
| Risk Factors | 1 | 2020 | 72145 | 0.030 |
Why?
|
| Fear | 1 | 2021 | 1436 | 0.030 |
Why?
|
| Social Perception | 1 | 2016 | 424 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2020 | 77098 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 2187 | 0.020 |
Why?
|
| Visual Perception | 1 | 2019 | 1417 | 0.020 |
Why?
|
| Anxiety | 1 | 2004 | 4279 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2004 | 6249 | 0.020 |
Why?
|
| Pyridines | 1 | 2001 | 2818 | 0.020 |
Why?
|
| Spectrum Analysis | 1 | 2010 | 451 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2016 | 6365 | 0.020 |
Why?
|
| Organ Size | 1 | 2012 | 2253 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 7716 | 0.020 |
Why?
|
| Depression | 1 | 2004 | 7733 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2012 | 21719 | 0.010 |
Why?
|
| Child | 2 | 2022 | 77478 | 0.010 |
Why?
|
| Prevalence | 1 | 2019 | 15194 | 0.010 |
Why?
|
| Receptors, Serotonin, 5-HT1 | 1 | 2001 | 13 | 0.010 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2001 | 178 | 0.010 |
Why?
|
| Aged | 1 | 2013 | 162944 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2010 | 8925 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2013 | 12017 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2022 | 40955 | 0.010 |
Why?
|
| Electroencephalography | 1 | 2013 | 6142 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 2011 | 3058 | 0.010 |
Why?
|
| Arousal | 1 | 2004 | 1165 | 0.010 |
Why?
|
| Reference Values | 1 | 2004 | 4982 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2004 | 2013 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 2001 | 1179 | 0.010 |
Why?
|
| Attention | 1 | 2004 | 2396 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 6474 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2004 | 2921 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2004 | 2896 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2001 | 2838 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 168561 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2011 | 40450 | 0.010 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(42)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_